Breaking News Instant updates and real-time market news.

KNX

Knight-Swift

$29.75 /

-0.65 (-2.14%)

12:30
05/24/19
05/24
12:30
05/24/19
12:30

Volatility play opened in Knight Transportation

Volatility play opened in Knight Transportation. The stock off 50c to $29.90 and 6K Jul 30 - 35 strangles trade $2.90. It looks like a buyer (bid-ask was $2.45 to 2.90) and the position has a bearish bias, as the puts are ITM and position delta is -.25. A long strangle expresses the view that shares could see an explosive move between now and expiration. Earnings expected again around 7/25 and the week after the 7/19/19 expiry.

  • 30

    May

  • 13

    Nov

KNX Knight-Swift
$29.75 /

-0.65 (-2.14%)

04/30/19 Baird
Amazon freight launch an overhang on domestic U.S. brokers, says Baird
03/05/19 Morgan Stanley
Echo Global upgraded to Equal Weight from Underweight at Morgan Stanley
02/01/19 Loop Capital
Loop Capital says take advantage of pullback in Knight-Swift
01/22/19 Wolfe Research
Knight-Swift downgraded to Peer Perform from Outperform at Wolfe Research

TODAY'S FREE FLY STORIES

Downgrade
SBA Communications downgraded to Sector Weight from Overweight at KeyBanc » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
SBAC

SBA Communications

$304.34 /

-3.44 (-1.12%)

KeyBanc analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

06/09/20 JPMorgan
SBA Communications upgraded to Overweight with $335 target at JPMorgan
06/09/20 JPMorgan
SBA Communications upgraded to Overweight from Neutral at JPMorgan
06/05/20 Deutsche Bank
SBA Communications resumed with a Buy at Deutsche Bank
05/06/20 Wells Fargo
SBA Communications price target raised to $325 from $305 at Wells Fargo
SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

SBAC SBA Communications
$304.34 /

-3.44 (-1.12%)

Downgrade
American Tower downgraded to Sector Weight from Overweight at KeyBanc » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
AMT

American Tower

$264.42 /

-1.41 (-0.53%)

KeyBanc analyst Brandon…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

06/09/20 JPMorgan
SBA Communications upgraded to Overweight with $335 target at JPMorgan
06/05/20 Deutsche Bank
American Tower resumed with a Buy at Deutsche Bank
05/22/20 Oppenheimer
American Tower upgraded to Outperform from Perform at Oppenheimer
05/22/20 Oppenheimer
American Tower upgraded to Outperform from Perform at Oppenheimer
AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

AMT American Tower
$264.42 /

-1.41 (-0.53%)

Conference/Events
Mesoblast participates in a conference call with Cantor Fitzgerald » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
MESO

Mesoblast

$13.08 /

+0.025 (+0.19%)

Conference call with…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

06/22/20 Dawson James
Channel checks dispute NY Times' COVID contention, says Dawson James
05/28/20 Ladenburg
Mesoblast price target raised to $15.25 from $13 at Ladenburg
05/28/20 H.C. Wainwright
Mesoblast price target raised to $21 from $14 at H.C. Wainwright
04/09/20 H.C. Wainwright
H.C. Wainwright 'encouraged' by Mesoblast's plan to study Ryoncil in ARDS
MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

MESO Mesoblast
$13.08 /

+0.025 (+0.19%)

Conference/Events
Gritstone Oncology to host conference call » 07:25
07/13/20
07/13
07:25
07/13/20
07:25
GRTS

Gritstone Oncology

$8.15 /

+1.05 (+14.79%)

Management holds a…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

07/26/19
Fly Intel: Top five analyst initiations
07/25/19 Baird
Gritstone Oncology initiated with an Outperform at Baird
GRTS Gritstone Oncology
$8.15 /

+1.05 (+14.79%)

Recommendations
D.R. Horton price target raised to $66 ahead of earnings at Seaport Global » 07:24
07/13/20
07/13
07:24
07/13/20
07:24
DHI

D.R. Horton

$58.64 /

+0.58 (+1.00%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

06/15/20 BTIG
D.R. Horton price target raised to $63 from $51 at BTIG
06/15/20 Citi
D.R. Horton price target raised to $69 from $56 at Citi
06/11/20 JPMorgan
PulteGroup upgraded, KB downgraded as JPMorgan adjusts homebuilder ratings
06/11/20 JPMorgan
D.R. Horton downgraded to Neutral from Overweight at JPMorgan
DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

DHI D.R. Horton
$58.64 /

+0.58 (+1.00%)

Hot Stocks
Summit announces publication of Phase 2 analyses of gut microbiome health » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
SMMT

Summit Therapeutics

$3.19 /

-0.02 (-0.62%)

Summit Therapeutics…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
SMMT Summit Therapeutics
$3.19 /

-0.02 (-0.62%)

SMMT Summit Therapeutics
$3.19 /

-0.02 (-0.62%)

03/19/20 H.C. Wainwright
Summit Therapeutics assumed with a Buy at H.C. Wainwright
Recommendations
Chegg price target raised to $86 from $80 at KeyBanc » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
CHGG

Chegg

$75.02 /

+2.31 (+3.18%)

KeyBanc analyst Jason…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

06/30/20 Citi
Chegg downgraded to Neutral from Buy at Citi
06/29/20 KeyBanc
Chegg initiated with an Overweight at KeyBanc
06/23/20 Northland
Chegg price target raised to $75 from $70 at Northland
06/22/20 Jefferies
Chegg price target raised to $80 from $55 at Jefferies
CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

CHGG Chegg
$75.02 /

+2.31 (+3.18%)

Hot Stocks
Hi-Crush Inc. files for Chapter 11 bankruptcy » 07:23
07/13/20
07/13
07:23
07/13/20
07:23
HCR

Hi-Crush Inc.

$0.16 /

-0.0047 (-2.90%)

Hi-Crush announced it has…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

03/09/20 Evercore ISI
Hi-Crush Inc. downgraded to Underperform from Outperform at Evercore ISI
11/07/19 AltaCorp
Hi-Crush Inc. downgraded to Underperform from Sector Perform at AltaCorp
HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

HCR Hi-Crush Inc.
$0.16 /

-0.0047 (-2.90%)

Hot Stocks
Cyclacel announces publication of peer-reviewed study of fadraciclib » 07:22
07/13/20
07/13
07:22
07/13/20
07:22
CYCC

Cyclacel Pharmaceuticals

$4.46 /

-0.02 (-0.45%)

Cyclacel Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

05/19/20 Brookline
Cyclacel Pharmaceuticals initiated with a Buy at Brookline
04/27/20
Fly Intel: Top five analyst initiations
04/27/20 Roth Capital
Cyclacel Pharmaceuticals assumed with a Buy at Roth Capital
CYCC Cyclacel Pharmaceuticals
$4.46 /

-0.02 (-0.45%)

Downgrade
Lennar downgraded to Neutral following outperformance at Seaport Global » 07:21
07/13/20
07/13
07:21
07/13/20
07:21
LEN

Lennar

$65.27 /

+2 (+3.16%)

, KBH

KB Home

$30.54 /

+1.485 (+5.11%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

07:17 Today Seaport Global
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds
06:29 Today Seaport Global
Lennar downgraded to Neutral from Buy at Seaport Global
06/18/20 Raymond James
Lennar price target raised to $75 from $41 at Raymond James
06/17/20 RBC Capital
Lennar price target raised to $68 from $61 at RBC Capital
KBH KB Home
$30.54 /

+1.485 (+5.11%)

07:17 Today Seaport Global
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds
06:35 Today Seaport Global
KB Home upgraded to Buy from Neutral at Seaport Global
06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Wells Fargo
KB Home price target raised to $33 from $24 at Wells Fargo
LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

Hot Stocks
Ovid Therapeutics, Angelini Pharma enter license agreement for OV101 » 07:21
07/13/20
07/13
07:21
07/13/20
07:21
OVID

Ovid Therapeutics

$7.47 /

-0.32 (-4.11%)

Ovid Therapeutics,and…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

06/18/20 Cantor Fitzgerald
Ovid Therapeutics price target raised to $13 from $7 at Cantor Fitzgerald
05/22/20 Cantor Fitzgerald
Zynerba price target raised to $21 from $12 at Cantor Fitzgerald
05/07/20 Piper Sandler
Ovid's gaboxadol data in Fragile X 'promising,' says Piper Sandler
03/30/20 Piper Sandler
Piper says Ovid data suggests potential use for soticlestat in CDD/Dup15q
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

  • 04
    Oct
OVID Ovid Therapeutics
$7.47 /

-0.32 (-4.11%)

Initiation
Teladoc initiated with a Buy at Argus » 07:20
07/13/20
07/13
07:20
07/13/20
07:20
TDOC

Teladoc

$229.30 /

+0.66 (+0.29%)

Argus analyst John Eade…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

07:07 Today Argus
Teladoc initiated with a Buy at Argus
07/06/20 Stephens
Teladoc initiated with an Overweight at Stephens
06/30/20 Piper Sandler
Virtual care market to benefit from PHE extension, says Piper Sandler
06/30/20 Piper Sandler
Piper survey shows over 10 times increase in telemedicine utilization
TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

TDOC Teladoc
$229.30 /

+0.66 (+0.29%)

Hot Stocks
electroCore announces FDA EUA for use of gammaCore Sapphire CV » 07:19
07/13/20
07/13
07:19
07/13/20
07:19
ECOR

electroCore

$0.85 /

-0.004 (-0.47%)

electroCore announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
ECOR electroCore
$0.85 /

-0.004 (-0.47%)

ECOR electroCore
$0.85 /

-0.004 (-0.47%)

03/10/20 H.C. Wainwright
electroCore initiated with a Buy at H.C. Wainwright
11/14/19 Cantor Fitzgerald
electroCore price target lowered to $4 from $9 at Cantor Fitzgerald
11/14/19 JMP Securities
electroCore downgraded to Market Perform from Outperform at JMP Securities
09/26/19 Cantor Fitzgerald
electroCore assumed with a Neutral at Cantor Fitzgerald
ECOR electroCore
$0.85 /

-0.004 (-0.47%)

Hot Stocks
Altimmune, University of Alabama anounces preclinical results for AdCOVID » 07:18
07/13/20
07/13
07:18
07/13/20
07:18
ALT

Altimmune

$22.32 /

+2.17 (+10.77%)

Altimmune announced…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

06/01/20 Roth Capital
Altimmune surprises with differentiated T-COVID study, says Roth Capital
05/06/20 Roth Capital
Novo data 'sets up the runway' for Altimmune, says Roth Capital
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
04/01/20
Roth Capital biotech analyst to hold an analyst/industry conference call
ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

ALT Altimmune
$22.32 /

+2.17 (+10.77%)

Upgrade
Seaport upgrades KB Home to Buy, sees some current headwinds becoming tailwinds » 07:17
07/13/20
07/13
07:17
07/13/20
07:17
KBH

KB Home

$30.54 /

+1.485 (+5.11%)

, LEN

Lennar

$65.27 /

+2 (+3.16%)

As previously reported,…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

06:35 Today Seaport Global
KB Home upgraded to Buy from Neutral at Seaport Global
06/25/20
Fly Intel: Top five analyst downgrades
06/25/20 Wells Fargo
KB Home price target raised to $33 from $24 at Wells Fargo
06/25/20 RBC Capital
KB Home price target lowered to $33 from $34 at RBC Capital
LEN Lennar
$65.27 /

+2 (+3.16%)

06:29 Today Seaport Global
Lennar downgraded to Neutral from Buy at Seaport Global
06/18/20 Raymond James
Lennar price target raised to $75 from $41 at Raymond James
06/17/20 RBC Capital
Lennar price target raised to $68 from $61 at RBC Capital
06/17/20 Wells Fargo
Lennar price target raised to $72 from $67 at Wells Fargo
KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

KBH KB Home
$30.54 /

+1.485 (+5.11%)

LEN Lennar
$65.27 /

+2 (+3.16%)

Periodicals
Toshiba chairman says it has recovered 50% of public trust, Nikkei reports » 07:17
07/13/20
07/13
07:17
07/13/20
07:17
TOSBF

Toshiba, also use TOSYY

$0.00 /

+ (+0.00%)

, TOSYY

Toshiba

$0.00 /

+ (+0.00%)

Toshiba's chairman…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

TOSYY Toshiba
$0.00 /

+ (+0.00%)

TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

04/22/20 UBS
Toshiba downgraded to Neutral from Buy at UBS
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
09/16/19 RBC Capital
Environment sets attractive entry points for Micron, Western, says RBC Capital
07/24/19 Jefferies
Toshiba initiated with an Underperform at Jefferies
TOSYY Toshiba
$0.00 /

+ (+0.00%)

04/22/20 UBS
Toshiba downgraded to Neutral from Buy at UBS
03/19/20 Citi
Toshiba upgraded to Neutral from Sell at Citi
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
11/27/19 Jefferies
Toshiba upgraded to Buy from Underperform at Jefferies
TOSBF Toshiba, also use TOSYY
$0.00 /

+ (+0.00%)

TOSYY Toshiba
$0.00 /

+ (+0.00%)

Hot Stocks
EyePoint appoints Jay Duker as chief strategic scientific officer » 07:16
07/13/20
07/13
07:16
07/13/20
07:16
EYPT

EyePoint

$0.75 /

+0.0481 (+6.81%)

EyePoint Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

04/06/20 B. Riley FBR
EyePoint downgraded to Neutral from Buy at B. Riley FBR
11/11/19 H.C. Wainwright
EyePoint downgraded to Neutral from Buy at H.C. Wainwright
09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
09/11/19 Guggenheim
EyePoint initiated with a Buy at Guggenheim
EYPT EyePoint
$0.75 /

+0.0481 (+6.81%)

  • 21
    Feb
Hot Stocks
Rocket Pharmaceuticals announces first patient treated in RP-L301 trial » 07:16
07/13/20
07/13
07:16
07/13/20
07:16
RCKT

Rocket Pharmaceuticals

$22.58 /

-1.06 (-4.48%)

Rocket Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

07/02/20 JPMorgan
Rocket Pharmaceuticals initiated with an Overweight at JPMorgan
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
06/25/20 BofA
Rocket Pharmaceuticals reinstated with a Buy at BofA
05/13/20 Piper Sandler
Rocket Pharmaceuticals programs look even more promising, says Piper Sandler
RCKT Rocket Pharmaceuticals
$22.58 /

-1.06 (-4.48%)

  • 11
    Dec
Hot Stocks
Calithera Biosciences initiates Phase 1b trial of CB-280 » 07:15
07/13/20
07/13
07:15
07/13/20
07:15
CALA

Calithera Biosciences

$5.14 /

-0.1 (-1.91%)

Calithera Biosciences…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

05/11/20 Citi
Calithera Biosciences price target raised to $10 from $7 at Citi
05/08/20 H.C. Wainwright
Calithera Biosciences price target raised to $9.50 from $7 at H.C. Wainwright
03/27/20
Fly Intel: Top five analyst initiations
03/27/20 Jefferies
Jefferies starts Calithera at Buy ahead of three data catalysts
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

  • 16
    Apr
CALA Calithera Biosciences
$5.14 /

-0.1 (-1.91%)

Hot Stocks
Tonix enters research, license agreement with Kansas State University » 07:14
07/13/20
07/13
07:14
07/13/20
07:14
TNXP

Tonix Pharmaceuticals

$0.64 /

-0.0208 (-3.16%)

Tonix Pharmaceuticals…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

08/30/19 Roth Capital
Tonix Pharmaceuticals price target lowered to $1.30 from $4 at Roth Capital
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

  • 16
    Jul
TNXP Tonix Pharmaceuticals
$0.64 /

-0.0208 (-3.16%)

Initiation
Royalty Pharma initiated with a Buy at SunTrust » 07:14
07/13/20
07/13
07:14
07/13/20
07:14
RPRX

Royalty Pharma

$47.55 /

-0.8 (-1.65%)

SunTrust analyst Gregg…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

06:32 Today BofA
Royalty Pharma initiated with a Buy at BofA
06:16 Today Morgan Stanley
Royalty Pharma initiated with an Equal Weight at Morgan Stanley
06:15 Today SunTrust
Royalty Pharma initiated with a Buy at SunTrust
06:15 Today Cowen
Royalty Pharma initiated with an Outperform at Cowen
  • 16
    Jun
RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

RPRX Royalty Pharma
$47.55 /

-0.8 (-1.65%)

Initiation
Atmos Energy initiated with a Buy at Seaport Global » 07:13
07/13/20
07/13
07:13
07/13/20
07:13
ATO

Atmos Energy

$99.12 /

+1.5 (+1.54%)

Seaport Global analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
ATO Atmos Energy
$99.12 /

+1.5 (+1.54%)

06/05/20 Mizuho
Atmos Energy price target lowered to $110 from $118 at Mizuho
04/01/20 UBS
Atmos Energy upgraded to Buy from Neutral at UBS
04/01/20 UBS
Atmos Energy upgraded to Buy from Neutral at UBS
03/23/20 Morgan Stanley
Morgan Stanley sees selective opportunities in U.S. utilities, changes 4 ratings
ATO Atmos Energy
$99.12 /

+1.5 (+1.54%)

Downgrade
MTY Food Group downgraded to Sell from Buy at Veritas » 07:13
07/13/20
07/13
07:13
07/13/20
07:13
MTYFF

MTY Food Group

$0.00 /

+ (+0.00%)

Veritas analyst Dimitry…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

Hot Stocks
Yamana Gold says cash on hand sufficient to fully manage business » 07:13
07/13/20
07/13
07:13
07/13/20
07:13
AUY

Yamana Gold

$5.51 /

-0.085 (-1.52%)

During the second…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

05/22/20 National Bank
Yamana Gold downgraded to Sector Perform from Outperform at National Bank
04/16/20 Scotiabank
Yamana Gold upgraded to Outperform from Sector Perform at Scotiabank
02/11/20 Stifel
Stifel upgrades Yamana to Buy on stronger position for 2020
02/11/20 Stifel
Yamana Gold upgraded to Buy from Hold at Stifel
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

Hot Stocks
Yamana Gold says Cerro Moro ramp-up was steady » 07:12
07/13/20
07/13
07:12
07/13/20
07:12
AUY

Yamana Gold

$5.51 /

-0.085 (-1.52%)

While ongoing government…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

05/22/20 National Bank
Yamana Gold downgraded to Sector Perform from Outperform at National Bank
04/16/20 Scotiabank
Yamana Gold upgraded to Outperform from Sector Perform at Scotiabank
02/11/20 Stifel
Stifel upgrades Yamana to Buy on stronger position for 2020
02/11/20 Stifel
Yamana Gold upgraded to Buy from Hold at Stifel
AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

AUY Yamana Gold
$5.51 /

-0.085 (-1.52%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.